ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Vertex On Building Risk Into Manufacturing Network Strategy

  Supply disruptions are becoming harder to predict. Explore practical strategies for continuity planning, supplier risk management, and network design to build lasting resilience.

• Inside A Gene Therapy Facility, Commercialization & Industrialization Project

  An inside look at a clinical-stage company focused on bringing its gene therapy from the lab into a clinical setting for patients and families devastated by rare neurological genetic diseases. 

• Demonstrating The Value Of Investigational Drug Services Through Time-Based Metrics

  Learn how adopting time-based metrics helps research teams accurately track workload, optimize staffing, and justify trial budgets.

• How Modern RTSM Platforms Are Eliminating Delays

  Stop letting rigid legacy RTSM systems stall your clinical trials. Learn why manual change requests cause months of delays and how a modern, platform-based approach restores your study’s agility.

• RTSM Reusability: What It Is, Why Most Systems Lack It, And Why It Matters

  Explore why RTSM should be viewed as a system for managing change. Learn how platform-based reusability reduces UAT churn, preserves institutional memory, and stabilizes mid-study amendments.

• The Crucial Role Of IRT/RTSM In Optimizing Drug Supply Budgets

  Expand your knowledge of IRT/RTSM systems and their capabilities to tailor supplies to site-specific recruitment, significantly decrease drug waste and costs, ensure efficient IMP management, and more.

• Optimizing Clinical Trials In China With Strategic Solutions For Supply Chain

  Plan proactively for clinical trials in China by aligning with National Medical Products Administration requirements and leveraging Free Trade Zones to streamline regulatory approvals and clinical supply importation.

• Revolutionizing Trial Supply Management With The Power Of Free Picking

  Discover the power of SmartSignals RTSM’s new free picking feature, designed to revolutionize trial supply management by optimizing efficiency and reducing costs.

• Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To Commercialization

  While in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharmaceuticals company sought a packaging recommendation: a stopper to maintain high-quality standards.

• What To Look For In Your IRT/RTSM Solution For A Simpler Trial Execution

  Which factors should you consider when selecting an IRT/RTSM vendor to ensure your trial's randomization and supply management processes are successfully executed?